Work

Supplementary Fig 2 from Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR+, HER2− Advanced Breast Cancer

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Fig 2

DOI: 10.1158/1078-0432.22477830

Authors: Aditya Bardia, Shanu Modi, Mafalda Oliveira, Javier Cortes, Mario Campone, Brigette Ma, Luc Dirix, Amy Weise, Becker Hewes, Ivan Diaz-Padilla, Yu Han, Priya Deshpande, Tanay S. Samant, Karen Rodriguez Lorenc, Wei He, Fei Su, Mariana Chavez-MacGregor

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361937816

Cites:

Cited by:

Related to: 10